|
CEP76 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.22570000000455E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.0002000000453E-06 |
| Normal-vs-Stage2 |
8.338200E-03 |
| Normal-vs-Stage3 |
9.164000E-02 |
| Normal-vs-Stage4 |
1.428870E-04 |
| Stage1-vs-Stage2 |
2.122000E-01 |
| Stage1-vs-Stage3 |
1.204830E-01 |
| Stage1-vs-Stage4 |
5.917400E-01 |
| Stage2-vs-Stage3 |
6.691400E-01 |
| Stage2-vs-Stage4 |
1.229440E-01 |
| Stage3-vs-Stage4 |
1.388970E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.62020000000052E-05 |
| Normal-vs-AfricanAmerican |
6.568000E-04 |
| Normal-vs-Asian |
4.718100E-02 |
| Caucasian-vs-AfricanAmerican |
9.616600E-01 |
| Caucasian-vs-Asian |
7.288200E-01 |
| AfricanAmerican-vs-Asian |
7.835400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.31240000000865E-06 |
| Normal-vs-Female |
1.845240E-01 |
| Male-vs-Female |
2.420800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.359900E-03 |
| Normal-vs-Extreme_Weight |
1.40239999613101E-08 |
| Normal-vs-Obese |
1.122880E-03 |
| Normal-vs-Extreme_Obese |
5.414300E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.115900E-02 |
| Normal_Weight-vs-Obese |
9.670200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.814800E-01 |
| Extreme_Weight-vs-Obese |
3.847900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.356000E-01 |
| Obese-vs-Extreme_Obese |
6.649000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.676300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.659540E-03 |
| Normal-vs-Age(61-80Yrs) |
2.44600000000039E-05 |
| Normal-vs-Age(81-100Yrs) |
2.2884999999917E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.197800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.209790E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.904180E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.315820E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.746000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.790380E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.4857999997584E-07 |
| Normal-VS-Type2 PRCC |
1.956690E-03 |
| Normal-VS-KIRP CIMP |
2.786400E-01 |
| Normal-VS-Unclassified PRCC |
9.377700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.827200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.541700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.273550E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.941800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.528800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.104200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.13000000000219E-05 |
| Normal-vs-N1 |
3.462200E-01 |
| Normal-vs-N2 |
5.121100E-03 |
| N0-vs-N1 |
7.374000E-02 |
| N0-vs-N2 |
3.788000E-01 |
| N1-vs-N2 |
1.730380E-01 |
|
|
